These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10375280)

  • 1. Challenges in Cancer Metastasis. Proceedings of the 14th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 11-12 September 1998.
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S1-103. PubMed ID: 10375280
    [No Abstract]   [Full Text] [Related]  

  • 2. New concepts of treatment strategies for hormone-related cancer. Proceedings of the 20th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. March 11-12, 2005. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():1-99. PubMed ID: 16273362
    [No Abstract]   [Full Text] [Related]  

  • 3. New therapeutic strategies for higher cure rates: high dose therapy and new therapeutic modalities. Proceedings of the 12th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 4-5 October 1996.
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S1-118. PubMed ID: 9289398
    [No Abstract]   [Full Text] [Related]  

  • 4. State of the art for digestive organs. Proceedings of the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. November 14-15, 2003. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S1-90. PubMed ID: 15614933
    [No Abstract]   [Full Text] [Related]  

  • 5. The 11th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Cytokines and New Anticancer Agents on the Horizon of Oncology. Nagoya, Japan, 24-25 November 1995.
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S1-119. PubMed ID: 8777775
    [No Abstract]   [Full Text] [Related]  

  • 6. 22nd annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research. Isaiah J. Fidler.
    Weinhouse S
    Cancer Res; 1999 Jun; 59(11):1 p preceding 2511. PubMed ID: 10363962
    [No Abstract]   [Full Text] [Related]  

  • 7. The 1st Bristol-Myers Squibb Symposium on Infectious Disease Research: the Cell and Molecular Biology of Bacterial-Host Cell Interactions. February 22-23, 1993, Monterey, California. Proceedings.
    Infect Agents Dis; 1993 Aug; 2(4):167-290. PubMed ID: 8173787
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of the 1st International Symposium on Cancer Metastasis and Lymphovascular System: Basis for Rational Therapy, April 28-30, 2005, San Francisco, California, USA.
    Cancer Metastasis Rev; 2006 Jun; 25(2):157-294. PubMed ID: 16770530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer metastasis: experimental and clinical strategies. Proceedings of a symposium. Kalamazoo, Michigan, September 15-17, 1985.
    Prog Clin Biol Res; 1986; 212():1-334. PubMed ID: 3714726
    [No Abstract]   [Full Text] [Related]  

  • 10. Entecavir (Bristol-Myers Squibb).
    Billich A
    Curr Opin Investig Drugs; 2001 May; 2(5):617-21. PubMed ID: 11569933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenesis and metastasis. The Second International Symposium of the Hiroshima Cancer Seminar, Hiroshima, Japan, June 1992.
    Tahara E; Yasui W; Yokozaki H
    J Cancer Res Clin Oncol; 1993; 119(9):560-3. PubMed ID: 8100824
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings of the 14th Symposium on Pharmacological Activity and Mechanism. Nagoya. Abstracts.
    J Pharmacobiodyn; 1986 Aug; 9(8):S89-103. PubMed ID: 3783408
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of basic science to hematopoiesis and treatment of disease. 15th Bristol-Myers Squibb Symposium on Cancer Research held at the Fred Hutchinson Cancer Research Center, Seattle, November 4-5, 1991.
    Mertelsmann R
    Ann Oncol; 1992 Apr; 3(4):269-72. PubMed ID: 1390304
    [No Abstract]   [Full Text] [Related]  

  • 14. Bristol-Myers Squibb-Edward E Smissman Award symposium.
    Rotella DP
    IDrugs; 1999 Nov; 2(11):1102-3. PubMed ID: 16113971
    [No Abstract]   [Full Text] [Related]  

  • 15. BMS-247550 Bristol-Myers Squibb/GBF.
    Lin N; Brakora K; Seiden M
    Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: the Bristol-Myers Squibb experience.
    Berman D; Korman A; Peck R; Feltquate D; Lonberg N; Canetta R
    Pharmacol Ther; 2015 Apr; 148():132-53. PubMed ID: 25476108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical determinants of metastasis.
    Fidler IJ
    Semin Cancer Biol; 2002 Apr; 12(2):89-96. PubMed ID: 12027580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMS-310705 Bristol-Myers Squibb/GBF.
    Kolman A
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1292-7. PubMed ID: 15648951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of the 15th International Conference on Flow Injection Analysis, Nagoya, Japan, 28 September-3 October 2008.
    Talanta; 2009 Sep; 79(4):977-1187. PubMed ID: 19780208
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular mechanisms of metastasis.
    Hoon DS; Kitago M; Kim J; Mori T; Piris A; Szyfelbein K; Mihm MC; Nathanson SD; Padera TP; Chambers AF; Vantyghem SA; MacDonald IC; Shivers SC; Alsarraj M; Reintgen DS; Passlick B; Sienel W; Pantel K
    Cancer Metastasis Rev; 2006 Jun; 25(2):203-20. PubMed ID: 16770533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.